U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07153237) titled 'Clinical Performance and Safety of STYLAGE(R) HydroMax' on Aug. 21.
Brief Summary: FHAME is a post-market clinical investigation designed to strengthen the clinical evidence supporting the effectiveness of STYLAGE(R) HydroMax in the treatment of superficial wrinkles, primarily on the cheeks.
Study Start Date: Sept. 09
Study Type: INTERVENTIONAL
Condition:
Aging
Aesthetic
Intervention:
DEVICE: STYLAGE(R) HydroMax
3 injection sessions : Group A: at week 0 (V1a), week 3 (V2a), and week 24 (V5a). Group B: at week 6 (V3b), week 3 from V3b (V4b), and week 24 from V3b (V7b)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Laboratoi...